Lv1
4 积分 2021-11-09 加入
Phase II study of the antibody-drug conjugate TAK-264 (MLN0264) in patients with metastatic or recurrent adenocarcinoma of the stomach or gastroesophageal junction expressing guanylyl cyclase C
2小时前
已完结
Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy
1年前
已完结
Anti-BCMA/CD19 CAR T Cells with Early Immunomodulatory Maintenance for Multiple Myeloma Responding to Initial or Later-Line Therapy
1年前
已完结
GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
1年前
已完结
Rationally designed redirection of natural killer cells anchoring a cytotoxic ligand for pancreatic cancer treatment
1年前
已完结
Functional T cells are capable of supernumerary cell division and longevity
1年前
已完结
Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
1年前
已完结
Discovery of a Potent and Selective STAT5 PROTAC Degrader with Strong Antitumor Activity In Vivo in Acute Myeloid Leukemia
1年前
已完结
Reversible ON- and OFF-switch chimeric antigen receptors controlled by lenalidomide
2年前
已完结
Modulation of the gut microbiota engages antigen cross-presentation to enhance antitumor effects of CAR T cell immunotherapy
2年前
已完结
皖公网安备34019202002308
